News was built in to the rapid SP escalation already seen. I'm surprised the SP hasnt weakened more as the current result is as forecast, ie no upside surprise. A 2c divvy and no great expectation of further dramatic improvements means there is no compelling reason to buy into API at this time.
- Forums
- ASX - By Stock
- News: Australian Pharmaceutical swings to profit
News was built in to the rapid SP escalation already seen. I'm...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add API (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online